On Wednesday, Shares of Magnum Hunter Resources Corp. (NYSE:MHR), gained 13.07% to $0.57.
Pennies are arguably the most useless form of currency in the U.S., but Utica shale driller Magnum Hunter Resources Corp. would sure love to have one, according to bizjournals.com
The Texas oil and gas producer could be delisted from the New York Stock Exchange because its shares are trading low – by an average of one cent.
Magnum Hunter (NYSE:MHR) recorded an average price of 99 cents as of August 26. Under New York Stock Exchange rules, a company’s average closing price must be a least $1 per share for 30 straight days.
The exchange has warned the company that its sub-$1 per share price means the company has six months to get up to acceptable levels before it is delisted. bizjournals.com Reports
Magnum Hunter Resources Corporation, an independent oil and gas company, explores for, exploits, acquires, develops, and produces crude oil, natural gas, and natural gas liquid resources in the United States. The company operates through the U.S. Upstream, Midstream, and Oilfield Services segments.
Shares of Delta Air Lines, Inc. (NYSE:DAL), inclined 0.43% to $47.09, during its last trading session.
Last week, Delta employees were told they will get their own ‘SkySpa.’ Now, they’re getting a nice pay raise, according to bizjournals.com.
Delta Air Lines Inc. (NYSE: DAL) stated Wednesday it will boost most employees’ base pay by 14.5 percent and is increasing its 401(k) dollar-for-dollar match from 5 to 6 percent.
The Atlanta-based airline stated the base pay rates will improvement for all eligible merit, ground and flight attendant employees around the world on Dec. 1. When combined with the April improvements, pay rates for most employees will be up 18 percent or more in 2015, providing record pay raises in a year of record profits.
Additionally, its new profit sharing formula for payouts in 2017 and after shares 10 percent of profits until the airline matches its prior-year profitability and then pays 20 percent of profits, with no limit.
On Jan. 1, Delta will start to match employees’ 401(k) contributions up to 6 percent of pay with automatic and matching contributions from the airline, which together can equal up to 8 percent of employee earnings, the total will add up to 14 percent of an employee’s earnings. bizjournals.com Reports
Delta Air Lines, Inc. provides planned air transportation for passengers and cargo worldwide. The company operates in two segments, Airline and Refinery. Its route network comprises various gateway airports in Amsterdam, Detroit, Los Angeles, Minneapolis-St. Paul, New York-LaGuardia, New York-JFK, Paris-Charles de Gaulle, Salt Lake City, Seattle, and Tokyo-Narita.
Shares of Endo International plc (NASDAQ:ENDP), inclined 4.38% to $79.30, during its last trading session.
Endo International a partner of Endo International plc and BioDelivery Sciences International, Inc. (BDSI) presented data from a Phase 2 study for the investigational drug buprenorphine HCl buccal film utilizing BDSI’s patented BioErodible MucoAdhesive (BEMA®) drug delivery technology. The findings, presented in a poster session at PAINWeek 2015 in Las Vegas , showed that study participants receiving around-the-clock therapy with an opioid full agonist (morphine or oxycodone) could be switched to buprenorphine HCl buccal film, at about half the full agonist dose, without increasing the risk of experiencing opioid withdrawal or a loss of pain relief. These findings also will be presented later this month at the 26th Annual Meeting of the American Academy of Pain Administration in National Harbor, MD.
Buprenorphine HCl buccal film is being developed under the proprietary name BELBUCA™ (buprenorphine HCl) buccal film and is presently under review by the U.S. Food and Drug Administration (FDA) for use in patients with pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. The PDUFA action date is in October 2015 .
Endo International plc, a specialty healthcare company, focuses on branded and generic pharmaceuticals and devices worldwide. It operates through four segments: U.S. Branded Pharmaceuticals, U.S. Generic Pharmaceuticals, Devices, and International Pharmaceuticals.
Finally, The Bank of New York Mellon Corporation (NYSE:BK), ended its last trade with 0.42% gain, and closed at $40.23.
Through the generosity of The Eugene F. Fay Trust, BNY Mellon has awarded operating support grants to 10 Boston-area nonprofits, providing them with critical funding for capacity-building activities. The Eugene F. Fay Trust Mini-Grants Program provides organizations with $5,000 grants for technical assistance and non-programmatic support aimed at strengthening the overall organization or a particular program. BNY Mellon is trustee of the Eugene F. Fay Trust and administers the mini-grants program.
“Nonprofits’ resources are increasingly stretched thin and often they face the challenge of providing critical services to people in need without the benefit of the latest technologies,” said Joanne Jaxtimer, Regional Executive of New England and Co-Head of Global Philanthropy for BNY Mellon. “Operating support assists to bridge the gap in budgets, allowing nonprofits to upgrade their technology and resources and run more efficiently. Through the generosity of The Eugene F. Fay Trust, we can enable nonprofits to focus on their missions and achieve their organizations’ social aims.”
The Bank of New York Mellon Corporation, an investment company, provides financial products and services to institutions, corporations, and high net worth individuals in the United States and internationally. It operates through two segments, Investment Administration and Investment Services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
